SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-126121
Filing Date
2023-12-15
Accepted
2023-12-15 06:02:16
Documents
2
Period of Report
2023-12-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2332814-3_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2332814-3_3seq1.xml 3 11538
2 EXHIBIT 24 tm2332814d3_ex24.htm EX-24 115355
  Complete submission text file 0001104659-23-126121.txt   129159
Mailing Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118
Business Address EMPIRE STATE BUILDING 350 5TH AVENUE, SUITE 5330 NEW YORK NY 10118 (646) 600-6438
IN8BIO, INC. (Issuer) CIK: 0001740279 (see all company filings)

IRS No.: 825462585 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN, SUITE 400 FORT WORTH TX 76107 817-984-9197
Bios Clinical Opportunity Fund, LP (Reporting) CIK: 0001988639 (see all company filings)

State of Incorp.: DE
Type: 3 | Act: 34 | File No.: 001-39692 | Film No.: 231488690

Mailing Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107
Business Address 1751 RIVER RUN SUITE 400 FORT WORTH TX 76107 817-345-6829
Bios Equity COF, LP (Reporting) CIK: 0002000747 (see all company filings)

State of Incorp.: TX | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39692 | Film No.: 231488689